SMS Pharmaceuticals Limits Shares for Unclaimed Dividends to IEPF
SMS Pharmaceuticals Limited has initiated steps regarding shares linked to unpaid or unclaimed dividends due to shareholders who have not claimed these amounts over seven consecutive years, necessitating their transfer to the Investor Education and Protection Fund (IEPF).The company confirmed that according to regulations requiring action when dividends remain unpaid for a period exceeding seven years, all corresponding shares must be transferred to the IEPF Account. This follows the principle that dividend declared by the Company is remitted either electronically or through dividend warrants sent to registered shareholders' addresses, with reminders periodically dispatched for claiming any unclaimed amounts.
The company noted that all unpaid dividends prior to the financial year 2018-2019 have already been transferred to the IEPF or Central Government. The specific dividends paid or remitted over the last seven years that remain unpaid or unclaimed include those from the following periods:
| Dividend Year |
|---|
| 2018-2019 |
| 2019-2020 INTERIM |
| 2020-2021 |
| 2021-2022 |
| 2022-2023 |
| 2023-2024 |
| 2024-2025 |
Shareholders who have shares tied to these unclaimed dividends are required to take immediate action. They must submit an application along with their KYC documents and the prescribed forms to Aarthi Consultants Pvt. Ltd., the Registrar and Transfer Agents of the Company, on or before October 25, 2026.
If shareholders fail to claim the outstanding dividends by the specified deadline, the company will transfer all related shares, whether held in physical or electronic form, to the IEPF Account without further notice. Shareholders are encouraged to update their PAN and KYC details with the Registrar and Transfer Agents to facilitate dividend remittance.
SMSPHARMA Stock Price Movement
SMS Pharmaceuticals Limited sheds value in real-time trading, with its stock price dipping by 1.37% and holding at ₹382.9 as of 12:33 PM. Traded volume stands at 107,658 shares, indicating sustained selling pressure across the market.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.